DSM and CVC finalize partnership for Polymer Intermediates and Composite Resins

04-Aug-2015 - Netherlands

Royal DSM and CVC Capital Partners (CVC) announced that the partnership for DSM's activities in Polymer Intermediates (caprolactam and Acrylonitrile) and Composite resins through the formation of a new company, ChemicaInvest B.V., has been finalized. With all regulatory approvals now received, DSM and CVC have completed the transaction effective as per 31 July 2015.

All approximately 1,900 employees have transferred to ChemicaInvest, which is 65% owned by CVC and 35% by DSM. DSM contributed its global caprolactam business (Europe, North America, its 60% stake in DNCC (China) and the caprolactam licensing business), acrylonitrile business and composite resins business including its 75% stake in JDR (China). DSM's 65% stake in the service organization Sitech Services held via its caprolactam and acrylonitrile businesses was also transferred.

Other news from the department business & finance

Most read news

More news from our other portals

Is artificial intelligence revolutionising chemistry?